elaros logo

ELAROS 24/7 is the world's first virtual lower urinary tract symptoms (LUTS) assessment clinic. ELAROS 24/7 provides an innovative new way of carrying out initial assessment, diagnosis and triaging, as well as the long term management & monitoring of patients. 

The company has been designed by clinicians and built by an exciting partnership that brings together the skills and expertise of the NHS, the academic community and industry.

ELAROS 24/7 provides a patient-centred service that integrates and enhances the delivery of the patient pathway and enables compliance with NICE guidelines.

The service blocks have been designed to be integrated with the existing services of GPs, specialist continence providers, community health organisations and acute trusts.

The Elaros 24/7 service

ELAROS 24/7 has been created by clinicians and provides an innovative new way of carrying out initial assessment, diagnosis and triaging of patients with lower urinary tract symptoms. The ELAROS 24/7 service has also been designed to care for patients who require long term management & monitoring. An important aspect of the innovative service is that it can also be used to efficiently and effectively determine patient responsiveness to different treatment regimes. 

patient
Improves patient
experience
time
Speeds-up
diagnosis
clinical
Increases clinical
accuracy
device
Easy
to use

Our service is centred on a hand held recording device that enables patients to monitor their own health both at home and on the move safely and discreetly. This information is then uploaded remotely to our system that provides an immediate clinical diagnosis and recommended clinical action.

This innovative new way of carrying out initial assessment, diagnosis and triaging of patients with lower urinary tract symptoms provides a patient-centred service that has been specifically designed to be integrated into GP practices, specialist continence providers, community health organisations and acute trusts.   The service enhances delivery of the patient pathway and enables compliance with NICE guidelines. 

Recording of symptoms by the patient using the device ensures accurate clinical analysis of data resulting in greatly reduced clinical referrals and unnecessary hospital visits.  The ELAROS 24/7 service is also designed to care for patients who require long term management.  The efficient and effective monitoring of patient responsiveness to treatment is an important aspect of the ELAROS service which provides 100% accuracy.

Our approach, which has been trialled in different clinical settings, provides immediate, accurate, simple and intuitive clinical direction. 

Patients

At some point in their life 2 out of every 3 adults will have a bladder related problem. Currently 5 million people over the age of 40 in the UK suffer from a form of bladder difficulty called 'overactive bladder'. Of these sufferers, nearly 750,000 have been prescribed drugs.

The ELAROS handheld device is easy to use for patients of all ages.  This simple process of recording information enables the patient to take control and management of bladder issues with dignity.  The device is discreet and convenient and the information captured is 100% secure.  Using the device enables the patient to keep an accurate up to date bladder diary wherever they are. 

The information gathered from the handheld is uploaded remotely to the cloud which provides an immediate clinical diagnosis and recommended clinical action. The system also produces lifestyle alerts to help patients manage their own condition.

With this comes the reduced need for patients to go back and forth to their GP and cuts out inappropriate and unnecessary referrals to hospitals.  The time taken to diagnose and treat a patient's symptoms is cut reducing anxiety for the patient and offering quick relief from symptoms that may have had a significant emotional impact on their life.

The Elaros 24/7 team and board

ELAROS 24/7 has been incubated over the past 3 years by Devices for Dignity (D4D) and two NHS Regional Innovation Hubs. ELAROS 24/7 represents a breakthrough, not only in terms of the innovative nature of its service model, but also in its partnership approach that brings together the NHS, the academic community and industry.

Devices for Dignity is a national pilot Department of Health programme set up to drive forward innovative new products, processes and services to help people with debilitating conditions deal with their daily challenges.

Medipex Ltd and NHS Innovations North are the UK NHS Innovation Hubs for Yorkshire & Humber and the North East Region. Their mission is to facilitate the development of services/products that cut costs and improve patient care.

Sheffield Teaching Hospital NHS Foundation Trust provides the clinical direction for ELAROS 24/7

The Board and Executive
Professor Paul O' Brien

Professor
Paul O'Brien

CEO

Professor Paul O' Brien was appointed CEO of Elaros 24/7 in April 2012.

Paul has held senior posts in the private sector (Chief Executive), local government (Chief Officer), health (Director in West Essex NHS Trust) and education (Head of Department).

He has previous venture start-up experience having established the Essex Development and Regeneration Agency with a turnover of £8.5 million and funds under management of £15 million - employing 60 planners, economists, surveyors, bid writers and fund managers.

He has extensive experience of public sector transformation having externalised a local government service and more recently the externalisation of a £33 Million NHS Service.

Paul also has broad non-executive board experience gained over a 15 year period and has completed the Institute of Directors Diploma in Company Direction.

He is a visiting lecturer to the University of Surrey on its MBA & MSc Entrepreneurship programmes.

Christopher Chapple

Professor
Christopher Chapple

Medical Director

Professor Christopher Chapple is a Consultant Urological Surgeon at Sheffield Teaching Hospitals and Visiting Professor at Sheffield Hallam University.  He has a particular interest in functional reconstruction of the lower urinary tract and the underlying pharmacological control mechanisms and provides a tertiary service in lower urinary tract reconstructive surgery.  He trained at the Middlesex Hospital where he subsequently completed his doctorate thesis, and continued there and at the Institute of Urology in London for his sub-specialist training.

He is Chairman of the International Relations Committee at the European Association of Urology, having previously been the Adjunct Secretary General responsible for Education and Past Director of the European School of Urology. He is editor-in-chief of the journal Neurourology and Urodynamics and is on the editorial board of several journals such as the British Journal of Urology, European Urology, Surgery and Current Opinion in Urology. He is an active member of many international urological associations and societies including the British Association of Urological Surgeons, the European Association of Urology, the International Continence Society, the Association of Academic European Urologists and the American Association of Genitourinary Surgeons. He has chaired a number of guidelines initiatives including the NICE Guidelines Development Group on male lower urinary tract symptoms. He was awarded the St Peter’s medal by the British Association of Urological Surgeons in 2011. Professor Chapple has co-authored over 350 articles in peer-reviewed Journals and has written several books and a number of book chapters.

Peter Cunliffe

Peter Cunliffe

Finance Director

Peter Cunliffe qualified as a Chartered Accountant in 1983, having trained in Birmingham with one of the then ‘Big 4’ accountancy firms, Deloitte Haskins and Sells.

Since qualifying, Peter has worked in various finance and accounting roles for a wide spectrum of businesses, both in terms of size (£3m up to £1.2bn turnover) and industry sector (including retail, engineering, steel stockholding, laboratory analysis and specialty chemicals).

His early positions were in large blue-chip companies, roles which gave him a full understanding of the importance of pertinent, current management information and the need for strict financial disciplines to augment performance and safeguard assets.

Recognising that most small companies do not need a full-time financial director, Peter set up Flex FD Ltd in 2004, providing a flexible financial direction service for start-up and early-stage companies, particularly in the life science and healthcare sectors, and has helped raise £7m in funding across 10 businesses. 

Angel Jimenez-Aranda

Dr. Angel
Jimenez-Aranda

Technology Development Manager

Angel has an extensive experience leading, managing and developing innovative technological solutions aimed at improving the efficiency and performance of services.

Angel is the technology development manager in ELAROS. In addition, he works as a project manager at the NIHR Devices for Dignity Healthcare Technology Co-operative (D4D), maximising the operational efficiency in the selection and execution of high impact research and technological development projects in the health sector. Prior to joining ELAROS and D4D, Angel worked in the Higher Education sector for 8 years as the director of a University College, Chief Operations Officer of a biomedical engineering research group, and manager of the Catalan University Quality Assurance Agency (AQU).

Paul Harris

Paul Harris

Chairman

Paul has held Chairman and non-Executive Director positions in various listed and non-listed SME companies across a wide range of industries and often at the earlier stage of their development. These companies have included digital imaging, IT, general engineering, quoted investment management and recently a healthcare company, where as Chairman of a group of specialist MRI private clinics he was instrumental in organising a number of funding rounds and the appointment of senior executives.

His earlier career was as a graduate trainee with Lucas Industries, a large blue-chip company, followed by positions at the MJI Corporation, an industrial conglomerate, and Dexion-Comino International, a proprietary manufacturer. He has a deep and broad knowledge across all main functions of business gained over 35 years in senior management positions, and has a B.Sc in Engineering Science from Southampton University and an MBA from Cranfield Business School.

Wendy Tindale

Professor
Wendy Tindale

Professor Wendy Tindale is Scientific Director of Medical Imaging & Medical Physics at Sheffield Teaching Hospitals NHS Foundation Trust and also Head of Nuclear Medicine for the Trust’s three sites.  As Consultant Clinical Scientist, she leads one of the largest NHS centres of medical technology in the UK where she oversees the delivery of a wide spectrum of clinical scientific developments and services. She has extensive experience in frontline patient care, service delivery and improvement, and healthcare innovation. She holds a Chair at the University of Sheffield and has a national role as Clinical Director of the ‘Devices for Dignity’ (D4D) Healthcare Technology Co-operative, an NIHR/TSB funded national research and technology transfer programme. She has an interest in combining clinical academic excellence with business opportunities through commercial translation of innovative medical technologies and has worked with both public and private sectors to facilitate successful collaborations.

Professor Tindale has published widely in the scientific literature, with over 120 publications, from imaging to bioengineering, and has successfully translated research outcomes for patient benefit. She has contributed to numerous national and international committees, including Royal College Working Parties and Government advisory bodies and acts as advisor to several research programmes and knowledge transfer initiatives.

Ailsa Anderson

Ailsa Anderson

Ailsa is the Programme Manager for the NHS Innovations North team which is the official technology transfer representative for the NHS in the North East and part of a national network of similar organisations. The Innovations North team systematically identifies, protects and exploits intellectual property (IP) generated by the regions NHS Trusts and Clinical Commissioning Groups and as a result, manage a wide ranging portfolio of innovative technologies and services with the associated IP, particularly where these present valuable commercialisation opportunities to industry.

Prior to joining NHS Innovations North in May 2014, Ailsa worked as Programme Manager for the North East Quality Observatory , highlighting quality improvement opportunities within the NHS.

Latest news

Elaros builds links with China on Technology Trade Mission

10/Mar/2016

Read More

Elaros wins Innovation Voucher for cyber security project

08/Feb/2016

Read More

Ambitious plans for Elaros in 2016 following fund raising

20/Jan/2016

Read More

ELAROS participates in the 4th NWC Connected Health Ecosystem

23/Apr/2015

Read More

Elaros 24/7 secures funding from
the Academic Health Science Network

22/May/2014

Read More

Elaros 24/7 wins prestigious
Bionow Award

14/Dec/2013

Read More

Digital bladder diary
could save NHS millions

7/May/2013

Read More

Virtual clinic to benefit
LUTS sufferers

13/Dec/2012

Read More
-.-

Contact Us

Elaros 24/7 Ltd
Electric Works,
Sheffield Digital Campus,
Sheffield S1 2BJ
T: 0114 286 6344
E: contact@elaros247.org.uk